Gene Therapy for Treatment of Duchenne Muscular Dystrophy
Focusing on gene therapy and exon skipping medications, an expert on Duchenne muscular dystrophy discusses current and emerging treatment options.
EP: 1.Clinical Presentation and Diagnosis of Duchenne Muscular Dystrophy
EP: 2.Communication of Duchenne Muscular Dystrophy Diagnosis and Coordination of Care
EP: 3.Current and Emerging Treatment Options and Management of Duchenne Muscular Dystrophy
Now Viewing
EP: 4.Gene Therapy for Treatment of Duchenne Muscular Dystrophy
Video content above is prompted by the following questions:
- Provide an overview of delandistrogene moxeparvovec, micro-dystrophin gene therapy, that received accelerated approval for Duchenne muscular dystrophy (DMD) in 2023.
- Discuss ongoing studies for fordadistrogene movaparvovec gene therapy and other exon skipping therapies.
Related Videos
Related Content
